News | Treatment Planning | May 10, 2016

Australian Healthcare Network Adopts MIM Software Radiotherapy Planning Solution

MIM Maestro software suite offers advanced tools for image fusion, contouring, deformable registration and automation

May 10, 2016 — MIM Software Inc. announced that GenesisCare Australia has selected MIM Maestro as their radiotherapy contouring and deformable registration solutions platform across the Genesis Cancer Care Network in Australia.

Genesis Cancer Care is the largest provider of radiotherapy in Australia, performing over 300,000 yearly radiation oncology treatments from its network of 27 sites across the region. An extensive evaluation led to MIM Software being selected as the preferred suite of products to address the increasing demands of complex treatment protocols, resource-intensive workflows and high patient volumes.

"We are very excited to be partnering with MIM Software," explained Keith Hansen, national executive manager at Genesis Cancer Care. "A great deal of time and effort was spent in evaluating an optimal solution that would allow us to incorporate advanced processes and technologies into our patient care workflows. We are continuously striving to provide high-quality care for patients, with clinical excellence in image management and treatment planning, a key outcome required of the partnership. By implementing MIM into our clinics we will ensure every patient in our care receives highly personalised and highly targeted treatments."

MIM Maestro is a medical software suite capable of solving complex problems through the use of advanced tools for image fusion, contouring, deformable registration and automation to enhance radiation therapy plans.

For more information: www.mimsoftware.com

Related Content

Videos | Radiation Therapy | February 20, 2019
ITN Associate Editor Jeff Zagoudis speaks with Vinai Gondi, M.D., director of research and CNS neuro-oncology at the
Study Unveils Blueprint for Treating Radiation-Resistant Brain Tumor

NIH-funded researchers showed how gliomas may be treated with radiation and drugs that block DNA repair. Image courtesy of Castro lab, Michigan Medicine, Ann Arbor

 

News | Radiation Therapy | February 19, 2019
February 19, 2019 — Researchers at the University of Michigan recently searched for new brain tumor treatments by exp
Videos | Radiation Therapy | February 15, 2019
ITN Associate Editor Jeff Zagoudis speaks with Vinai Gondi, M.D., director of research and CNS neuro-oncology at the
New Targeted Therapy for Recurrent Brain Tumors Implanted for First Time
News | Radiation Therapy | February 15, 2019
University of Minnesota Health (M Health) is the first in the United States to begin offering GammaTile Therapy, a new...
Canon Adds Radiation Therapy Package to Aquilion Prime, Lightning CT Systems
News | Computed Tomography (CT) | February 11, 2019
In the patient-centric world of radiation oncology, it is critical that computed tomography (CT) simulation is...
Elekta Unity MR-Linac Earns FDA Clearance
Technology | Image Guided Radiation Therapy (IGRT) | February 07, 2019
The Elekta Unity magnetic resonance radiation therapy (MR/RT) system recently received 510(k) premarket notification...
University of Oklahoma Cancer Center Begins First Proton Therapy Treatments
News | Proton Therapy | February 01, 2019
Home to the largest and most comprehensive radiation therapy program in Oklahoma, the Stephenson Cancer Center at OU (...
Stereotactic Radiotherapy Improves Long-Term Survival in Stage-IV Cancers
News | Stereotactic Body Radiation Therapy (SBRT) | January 31, 2019
The first report from a phase II, multi-center clinical trial indicates stereotactic radiation can extend long-term...
Philips Collaborates With MIM Software on Radiation Therapy Treatment Planning
News | Treatment Planning | January 31, 2019
January 31, 2019 — Philips announced a collaboration with imaging solutions provider MIM Software Inc.
Videos | Lung Cancer | January 29, 2019
Gregory Videtic, M.D., staff physician in radiation oncology at the Cleveland Clinic, and David Johnstone, M.D., prof